ALNY Historical Earnings image   This ALNY historical earnings page last updated 8/1/2022
ALNY Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20227/28/20220.22B
Q1 20224/28/20220.21B
Q4 20212/10/20220.26B
Q3 202110/28/20210.19B
Q2 20218/3/20210.22B
Q1 20214/29/20210.18B
Q4 20202/11/20210.16B
Q3 202011/5/20200.13B
Q2 20208/6/20200.10B
Q1 20205/6/20200.10B
Q4 20192/6/20200.07B
Q3 201910/31/20190.07B
Q2 20198/6/20190.04B
Q1 20195/1/20190.03B
Q4 20182/7/201921.03M
Q3 201811/7/20182.07M
Q2 20188/2/201829.91M
Q1 20185/3/201821.90M
Q4 20172/8/201837.92M
Q3 201711/7/201717.10M
Q2 20178/9/201715.93M
Q1 20175/5/201718.96M
Q4 20162/8/201717.45M
Q3 201611/2/201613.65M
Q2 20168/4/20168.71M
Q1 20165/2/20167.34M
Q4 20152/11/20167.55M
Q3 201511/9/20156.32M
Q2 20158/6/20158.69M
Q1 20155/7/201518.54M
Q4 20142/12/201524.02M
Q3 201411/5/201410.97M
Q2 20148/7/20147.29M
Q1 20145/8/20148.30M
Q4 20132/13/201410.80M
Q3 201311/6/20139.00M
Q2 20138/8/20138.70M
Q1 20135/6/201318.60M
Q4 20122/7/20138.50M
Q3 201211/5/201216.80M
Q2 20128/6/201220.90M
Q1 20125/3/201220.59M
ALNY Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q2 20227/28/2022-2.030
Q1 20224/28/2022-1.490
Q4 20212/10/2022-1.690
Q3 202110/28/2021-1.510
Q2 20218/3/2021-1.300
Q1 20214/29/2021-1.640
Q4 20202/11/2021-1.600
Q3 202011/5/2020-1.580
Q2 20208/6/2020-1.670
Q1 20205/6/2020-1.520
Q4 20192/6/2020-1.980
Q3 201910/31/2019-1.500
Q2 20198/6/2019-1.830
Q1 20195/1/2019-1.730
Q4 20182/7/2019-1.82
Q3 201811/7/2018-1.56
Q2 20188/2/2018-1.61
Q1 20185/3/2018-1.22
Q4 20172/8/2018-1.2
Q3 201711/7/2017-1.06
Q2 20178/9/2017-1.34
Q1 20175/5/2017-1.25
Q4 20162/8/2017-1.32
Q3 201611/2/2016-1.21
Q2 20168/4/2016-1.05
Q1 20165/2/2016-1.21
Q4 20152/11/2016-1.07
Q3 201511/9/2015-0.91
Q2 20158/6/2015-0.85
Q1 20155/7/2015-0.62
Q4 20142/12/2015-0.28
Q3 201411/5/2014-0.58
Q2 20148/7/2014-0.41
Q1 20145/8/2014-0.39
Q4 20132/13/2014-0.51
Q3 201311/6/2013-0.48
Q2 20138/8/2013-0.29
Q1 20135/6/2013-0.15
Q4 20122/7/2013-1.2
Q3 201211/5/2012-0.38
Q2 20128/6/2012-0.25
Q1 20125/3/2012-0.25
Quotes delayed 20 minutes

Email EnvelopeFree ALNY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Alnylam Pharmaceuticals (ALNY) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ALPN Historical Earnings
ALRN Historical Earnings
ALT Historical Earnings
ALVR Historical Earnings
ALXN Historical Earnings
ALXO Historical Earnings
ALZN Historical Earnings
AMED Historical Earnings
AMEH Historical Earnings
AMGN Historical Earnings
What was the record high ALNY historical earnings result?
In terms of earnings or revenue, what is the best ALNY historical earnings result that Alnylam Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest ALNY historical earnings result was set in Q1 2013, when Alnylam Pharmaceuticals posted results of -0.15/share. The most successful revenue quarter within our data set was Q4 2021 when Alnylam Pharmaceuticals reported revenue of 0.26B.

What was the lowest Alnylam Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest ALNY has reported, and when?

✔️Accepted answer: Within our data set, the lowest ALNY historical earnings result was set in Q2 2022, when Alnylam Pharmaceuticals posted results of -2.030/share. The smallest revenue quarter within our data set was Q3 2018 when Alnylam Pharmaceuticals reported revenue of 2.07M.

On this page we presented the ALNY historical earnings date information for Alnylam Pharmaceuticals. Reviewing that ALNY Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2013, when ALNY posted adjusted EPS of -0.15/share. Meanwhile the lowest ALNY historical earnings result was in Q2 2022, when ALNY posted adjusted EPS of -2.030/share. Moving to Alnylam Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2021 when ALNY reported 0.26B in revenue, while the smallest revenue quarter was Q3 2018 when ALNY reported 2.07M in revenue.

For self directed investors doing their due diligence on ALNY or any other given stock, their research can benefit from looking into all of the Alnylam Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Alnylam Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for ALNY. Thanks for visiting, and the next time you need to research ALNY historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: CFF Historical Stock Prices, ELGX market cap history, SMIT Videos.

 

ALNY Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.